- Home
- BEEM vs EVAX Comparison
BEEM vs EVAX Comparison
Compare BEEM & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BEEM | EVAX |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | Denmark |
| Employees | 276 | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1M | 27.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BEEM | EVAX |
|---|---|---|
| Price | $1.48 | $4.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.00 | ★ $11.67 |
| AVG Volume (30 Days) | ★ 308.3K | 26.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $49.29 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $1.20 |
| 52 Week High | $4.04 | $12.15 |
Technical Indicators
Market Signals| Indicator | BEEM | EVAX |
|---|---|---|
| Relative Strength Index (RSI) | 44.42 | 64.00 |
| Support Level | $1.40 | $2.70 |
| Resistance Level | $1.88 | $5.48 |
| Average True Range (ATR) | 0.10 | 0.32 |
| MACD | 0.00 | 0.16 |
| Stochastic Oscillator | 26.79 | 76.06 |
Price Performance
Historical ComparisonAbout BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.